| 臺大學術典藏 |
2022-09-15T01:08:46Z |
Exposure-Response Relationships in Patients With HER2-Positive Metastatic Breast Cancer and Other Solid Tumors Treated With Trastuzumab Deruxtecan
|
Yin O.; Iwata H.; Chia-Chi Lin; Tamura K.; Watanabe J.; Wada R.; Kastrissios H.; AbuTarif M.; Garimella T.; Lee C.; Zhang L.; Shahidi J.; LaCreta F. |
| 臺大學術典藏 |
2022-08-19T00:20:33Z |
Pembrolizumab for the treatment of programmed death�Vligand 1?positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYnote-028 study
|
?lez E.; Tamura K.; Gould M.; Yang P.; Stein K.; Piha-Paul S.A.; Mehnert J.M.; Bergsland E.; O��Neil B.H.; Santoro A.; Schellens J.H.M.; Cohen R.B.; Doi T.; Ott P.A.; Pishvaian M.J.; Puzanov I.; Aung K.L.; CHIUN HSU; Le Tourneau C.; Hollebecque A. |
| 臺大學術典藏 |
2022-04-15T02:42:33Z |
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
|
Harbeck, N; Rastogi, P; Martin, M; Tolaney, S M; Shao, Z M; Fasching, P A; CHIUN-SHENG HUANG; Jaliffe, G G; Tryakin, A; Goetz, M P; Rugo, H S; Senkus, E; Testa, L; Andersson, M; Tamura, K; Del Mastro, L; Steger, G G; Kreipe, H; Hegg, R; Sohn, J; Guarneri, V; Cortés, J; Hamilton, E; André, V; Wei, R; Barriga, S; Sherwood, S; Forrester, T; Munoz, M; Shahir, A; San Antonio, B; Nabinger, S C; Toi, M; Johnston, S R D; O'Shaughnessy, J |
| 臺大學術典藏 |
2022-03-10T06:15:00Z |
Regulatory and operational challenges in conducting Asian International Academic Trial for expanding the indications of cancer drugs
|
Hata T.; Nakamura K.; Yonemori K.; Noguchi E.; Watanabe M.; Sohn J.; YEN-SHEN LU; Yap Y.-S.; Tamura K.; Fujiwara Y. |
| 臺大學術典藏 |
2022-03-10T06:14:59Z |
An Overview of the Treatment Efficacy and Side Effect Profile of Pharmacological Therapies in Asian Patients with Breast Cancer
|
YEN-SHEN LU; Yeo W.; Yap Y.-S.; Park Y.H.; Tamura K.; Li H.; Cheng R. |
| 臺大學術典藏 |
2021-07-28T06:46:37Z |
Insights into Breast Cancer in the East vs the West: A review
|
Yap Y.-S.; Lu Y.-S.; Tamura K.; Lee J.E.; Ko E.Y.; Park Y.H.; Cao A.-Y.; CHING-HUNG LIN; Toi M.; Wu J.; Lee S.-C. |
| 臺大學術典藏 |
2021-02-18T01:45:22Z |
Pembrolizumab for the treatment of programmed death�Vligand 1?positive advanced carcinoid or pancreatic neuroendocrine tumors: Results from the KEYNOTE-028 study
|
Mehnert J.M.;Bergsland E.;O??Neil B.H.;Santoro A.;Schellens J.H.M.;Cohen R.B.;Doi T.;Ott P.A.;Pishvaian M.J.;Puzanov I.;Aung K.L.;Chiun Hsu;Le Tourneau C.;Hollebecque A.;?Lez E.;Tamura K.;Gould M.;Yang P.;Stein K.;Piha-Paul S.A.; Mehnert J.M.; Bergsland E.; O��Neil B.H.; Santoro A.; Schellens J.H.M.; Cohen R.B.; Doi T.; Ott P.A.; Pishvaian M.J.; Puzanov I.; Aung K.L.; Chiun Hsu; Le Tourneau C.; Hollebecque A.; ?lez E.; Tamura K.; Gould M.; Yang P.; Stein K.; Piha-Paul S.A. |
| 臺大學術典藏 |
2021-01-05T00:56:27Z |
Long-term effects of crizotinib in ALK-positive tumors (excluding NSCLC): A phase 1b open-label study
|
Braiteh F.; Zhang L.; Orlov S.; Gambacorti-Passerini C.; Huang H.; Esaki T.; Horibe K.; Ahn J.-S.; Beck J.T.; Edenfield W.J.; Shi Y.; Taylor M.; Tamura K.; Van Tine B.A.; SHANG-JU WU; Paolini J.; Selaru P.; Kim T.M. |
| 臺大學術典藏 |
2020-05-25T07:35:07Z |
Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancer
|
Saraf S; Thanigaimani P; Cheng J.D; Keam B.; Mehnert J.M; Varga A; Brose M.S; Aggarwal R.R; Chia-Chi Lin; Prawira A; De Braud F; Tamura K; Doi T; Piha-Paul S.A; Gilbert J |
| 臺大學術典藏 |
2020-05-25T06:51:42Z |
Insights into Breast Cancer in the East vs the West: A Review
|
Yap Y.-S;Yen-Shen Lu;Tamura K;Lee J.E;Ko E.Y;Park Y.H;Cao A.-Y;Lin C.-H;Toi M;Wu J;Lee S.-C.; Yap Y.-S; YEN-SHEN LU; Tamura K; Lee J.E; Ko E.Y; Park Y.H; Cao A.-Y; Lin C.-H; Toi M; Wu J; Lee S.-C. |
| 臺大學術典藏 |
2020-03-27T05:30:42Z |
Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever
|
Jootar S.; Picazo J.J.; Liu Y.-C.; Suwangool P.; Lin S.-F.; PO-REN HSUEH; Liu C.-Y.; Ong A.; Chua M.; Hussain Y.; Picazo J.J.;Jootar S.;Suwangool P.;Liu Y.-C.;Lin S.-F.;PO-REN HSUEH;Liu C.-Y.;Ong A.;Chua M.;Hussain Y.;Ahmed A.;Lim V.;Purushotaman S.V.;Lee D.-G.;Matsumoto T.;Tamura K.;Ranuhardy D.;Reksodiputro A.H.;Chun W.;Zhixiang S.;Jun H.X.; Jun H.X.; Zhixiang S.; Chun W.; Reksodiputro A.H.; Ranuhardy D.; Tamura K.; Matsumoto T.; Lee D.-G.; Purushotaman S.V.; Lim V.; Ahmed A. |
| 臺北醫學大學 |
2005 |
Clinical guidelines for the monogement of cancer patients with neutropenia and unexplained fever.
|
劉永慶; Jun HX; Zhixiang S; Chun W; Reksodiputro AH; Ranuhardy D; Tamura K; Matsumoto T; Lee DG; Purushotaman SV; Lim V; Ahmed A; Hussain Y; Chua M; Ong A; Liu YC |
| 臺大學術典藏 |
2005 |
Clinical guidelines for the management of cancer patients with neutropenia and unexplained fever
|
Jun H.X.;Zhixiang S.;Chun W.;Reksodiputro A.H.;Ranuhardy D.;Tamura K.;Matsumoto T.;Lee D.-G.;Purushotaman S.V.;Lim V.;Ahmed A.;Hussain Y.;Chua M.;Ong A.;Liu C.-Y.;Po-Ren Hsueh;Lin S.-F.;Liu Y.-C.;Suwangool P.;Jootar S.;Picazo J.J.; Jun H.X.; Zhixiang S.; Chun W.; Reksodiputro A.H.; Ranuhardy D.; Tamura K.; Matsumoto T.; Lee D.-G.; Purushotaman S.V.; Lim V.; Ahmed A.; Hussain Y.; Chua M.; Ong A.; Liu C.-Y.; PO-REN HSUEH; Lin S.-F.; Liu Y.-C.; Suwangool P.; Jootar S.; Picazo J.J. |
